Foundation for Innovative New Diagnostics

Liam Sturgess
7 min read
Foundation for Innovative New Diagnostics

The Foundation for Innovative New Diagnostics (FIND) is an international non-governmental organization based in Geneva, Switzerland.

History

On April 24, 2020, FIND co-hosted an event to launch the Access to COVID-19 Tools Accelerator (ACT-Accelerator), an initiative to raise financial support for accelerated research and development, production, and access to COVID-19 tests, therapies, and vaccines.[1]

FIND co-designed the Global Pandemic Preparedness Summit 2024, which took place on July 29-30, 2024, in Rio de Janeiro, Brazil.[2]

Organization

FIND is part of the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) network.[3]

Personnel

Name Position Notes
Ayoade Alakija Chair[4] Access to COVID-19 Tools Accelerator, African Vaccine Delivery Alliance (AVDA), Government of Nigeria
Marta Fernández Suárez Chief Technology Officer[5] Daktari Diagnostics
Rick Bright Board Member[6] Pandemic Prevention Institute (PPI), Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR)
Emmanuel Agogo Director, Pandemic Threats Programme[7] Nigeria Centre for Disease Control and Prevention (NCDC), Resolve to Save Lives

Partners

FIND is a partner of:

  • CommonTrust Network[8]
  • Fleming Fund[9]
  • G20 Health & Development Partnership[10]
  • Global Antibiotic Research & Development Partnership (GARDP)[11]
  • Global Outbreak Alert and Response Network (GOARN)[12]
  • H20 Summit[13]
  • Medicines for Malaria Venture (MMV)[14]
  • Pandemic Action Network[15]
  • RBM Partnership to End Malaria[16]

Funding

FIND has received funding from:[17][18][19]

  • Access to COVID-19 Tools Accelerator (ACT-Accelerator)[20]
  • Anesvad
  • African Society for Laboratory Medicine (ASLM)
  • Australian Aid
  • BD[21]
  • Bill & Melinda Gates Foundation
  • BlackRock Foundation[22]
  • Boston University
  • Centers for Disease Control and Prevention (CDC)
  • Centre for Cellular and Molecular Biology (CCMB)[20:1]
  • Centre for Health Research and Innovation[20:2]
  • Centre for Infectious Disease Research in Zambia (CIDRZ)
  • Challenge TB[21:1]
  • Clinton Health Access Initiative (CHAI)[20:3]
  • Coalition for Epidemic Preparedness Innovations (CEPI)
  • Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)
  • CRDF Global
  • Delhi Network of Positive People (DNP+)[21:2]
  • Department of Foreign Affairs and Trade
  • Department of Health and Social Care
  • Drugs for Neglected Diseases Initiative (DNDi)
  • ELMA Foundation
  • END Fund
  • European and Developing Countries Clinical Trials Partnership (EDCTP)
  • European Commission[23]
  • European Union
  • Federal Ministry for Economic Cooperation and Development
  • Federal Ministry of Education and Research
  • Fleming Fund
  • Fondation Botnar
  • Foreign, Commonwealth and Development Office (FCDO)
  • Foundation for Scientific and Technological Development in Health (FIOTEC)
  • Foundation to Promote Open Society (FPOS)
  • Fundación Probitas
  • FutureLearn[20:4]
  • Gavi, the Vaccine Alliance
  • Gilead Sciences[20:5]
  • Global Affairs Canada
  • Global Antimicrobial Resistance Innovation Fund (GAMRIF)
  • Global BioDiagnostics[24]
  • The Global Fund
  • Global Health Innovative Technology Fund (GHIT Fund)
  • Google[25]
  • Gordon and Betty Moore Foundation
  • Government of Kuwait
  • Government of Manipur[21:3]
  • Government of National Capital Territory of Delhi[21:4]
  • Government of Portugal
  • Government of Punjab[21:5]
  • Horizon 2020
  • Indian Council of Medical Research (ICMR)[20:6]
  • Institute of Liver and Biliary Sciences (ILBS)[21:6]
  • Intellectual Ventures[24:1]
  • International Committee of the Red Cross (ICRC)
  • International Tuberculosis Research Center (ITRC)[21:7]
  • International Union Against Tuberculosis and Lung Disease[26]
  • Irish Aid[25:1]
  • Janssen[20:7]
  • Jhpiego
  • John Snow, Inc. (JSI)[26:1]
  • JSI Research & Training Institute
  • KfW
  • KHPT[20:8]
  • King George's Medical University (KGMU)[20:9]
  • Kingdom of Saudi Arabia Ministry of Health
  • KNCV Tuberculosis Foundation
  • Leona M. and Harry B. Helmsley Charitable Trust
  • London School of Hygiene and Tropical Medicine[20:10]
  • Medicor Foundation
  • Ministry of Foreign Affairs of the Netherlands
  • Mongolia Ministry of Health
  • Municipal Corporation of Greater Mumbai[20:11]
  • MYRADA[20:12]
  • National Institute of Immunology (NII)[20:13]
  • National Institutes of Health (NIH)
  • National Tuberculosis Elimination Programme (NTEP)[27]
  • Norwegian Agency for Development Cooperation (Norad)
  • Optum
  • PanIIT Alumni Foundation[20:14]
  • Patrick J. McGovern Foundation
  • Paul G. Allen Family Foundation
  • PepsiCo
  • Permanent Mission of the State of Kuwait to the United Nations
  • Program for Appropriate Technology in Health (PATH)[21:8]
  • Republic and State of Geneva
  • Research Investment for Global Health Technology Foundation (RIGHT Foundation)
  • Resolve to Save Lives
  • Rockefeller Foundation
  • Save the Children International[28]
  • South African Medical Research Council (SAMRC)
  • State Secretariat for Education, Research and Innovation (SERI)
  • Stop TB Partnership
  • Swiss Agency for Development and Cooperation (SDC)
  • Swiss Tropical and Public Health Institute (Swiss TPH)[22:1]
  • Tata Institute of Fundamental Research (TIFR)[20:15]
  • TB Alert India[20:16]
  • TB REACH
  • Tetra Pak
  • Top Institute Pharma[29]
  • Trafigura Foundation
  • UBS Optimus Foundation
  • UKaid
  • Unitaid
  • United Nations Office for Project Services (UNOPS)
  • United States Agency for International Development (USAID)
  • University of New South Wales (UNSW)
  • Wellcome Trust
  • World Bank
  • World Health Organization (WHO)
  • World Health Partners (WHP)[20:17]
  • YR Gaitonde Centre for AIDS Research and Education (YRGCARE)[21:9]

Activities

FIND has provided funding to:

  1. What is the ACT-Accelerator. World Health Organization. Retrieved February 12, 2023, from http://archive.today/2023.02.12-175054/https://www.who.int/initiatives/act-accelerator/about ↩︎

  2. Global Pandemic Preparedness Summit. Coalition for Epidemic Preparedness Innovations. Retrieved August 10, 2024, from https://web.archive.org/web/20240810004556/https://cepi.net/gpps ↩︎

  3. Global Accelerator Network. CARB-X. Retrieved June 6, 2022, from http://archive.today/2022.06.06-075409/https://carb-x.org/partners/global-accelerator-network/ ↩︎

  4. Ayoade (Yodi) Alakija, Chair. Foundation for Innovative New Diagnostics. Retrieved September 4, 2025, from http://archive.today/2025.09.04-014041/https://www.finddx.org/about-us/people/board/ayoade-yodi-alakija-chair/ ↩︎

  5. Marta Fernández Suárez. Foundation for Innovative New Diagnostics. Retrieved February 23, 2024, from https://web.archive.org/web/20240223092531/https://www.finddx.org/about-us/people/secretariat/marta-fernandez-suarez/ ↩︎

  6. Rick Bright. Foundation for Innovative New Diagnostics. Retrieved September 4, 2025, from http://archive.today/2025.09.04-014525/https://www.finddx.org/about-us/people/board/rick-bright ↩︎

  7. Emmanuel Agogo. Foundation for Innovative New Diagnostics. Retrieved September 11, 2025, from http://archive.today/2025.09.11-003316/https://www.finddx.org/about-us/people/leadership/emmanuel-agogo/ ↩︎

  8. Home. CommonTrust Network. Retrieved April 14, 2021, from https://web.archive.org/web/20210414122116/http://www.commontrustnetwork.org/ ↩︎

  9. Partners. Fleming Fund. Retrieved June 6, 2022, from http://archive.today/2022.06.06-135244/https://www.flemingfund.org/about-us/partners/ ↩︎

  10. Partners. G20 Health & Development Partnership. Retrieved December 7, 2022, from https://web.archive.org/web/20221207074334/https://g20healthpartnership.com/partners/ ↩︎

  11. Balasegaram, M., & Laxminarayan, R. (2022, October 14). GARDP Interactive Activity Report 2021. GARDP. https://web.archive.org/web/20230308232439/https://gardp.org/publications/gardp-interactive-activity-report-2021/ ↩︎

  12. About Us. GOARN. Retrieved March 14, 2023, from https://web.archive.org/web/20230314222154/https://goarn.who.int/#aboutus ↩︎

  13. Partners. G20 Health & Development Partnership. Retrieved December 7, 2022, from https://web.archive.org/web/20221207074334/https://g20healthpartnership.com/partners/ ↩︎

  14. Other product development partnerships (PDPs). Medicines for Malaria Venture. Retrieved July 17, 2022, from https://web.archive.org/web/20220717220929/https://www.mmv.org/other-product-development-partnerships-pdps ↩︎

  15. Our Network. Pandemic Action Network. Retrieved July 23, 2022, from https://web.archive.org/web/20220724022128/https://www.pandemicactionnetwork.org/our-network/ ↩︎

  16. Partners. RBM Partnership to End Malaria. Retrieved September 21, 2022, from https://web.archive.org/web/20220921232738/https://endmalaria.org/about-us/governance/partner ↩︎

  17. Partners & Donors. Foundation for Innovative New Diagnostics. Retrieved May 23, 2021, from http://archive.today/2021.05.23-093639/https://www.finddx.org/partners-donors/ ↩︎

  18. Alakija, A. (2025, January 21). Activity Report 2023 (p. 25). Foundation for Innovative New Diagnostics. https://web.archive.org/web/20250904014148/https://www.finddx.org/wp-content/uploads/2025/01/20250121_activity_report_2023_FV_EN.pdf ↩︎

  19. Kessel, M., & Rodriguez, B. (2022, December 8). 2015-2020 Impact Report (p. 23). Foundation for Innovative New Diagnostics. https://web.archive.org/web/20231217083152/https://www.finddx.org/wp-content/uploads/2022/12/20221208_activity_report_2020_FV_EN.pdf ↩︎

  20. Activity Report India 2020 (p. 19). (2022, December 8). Foundation for Innovative New Diagnostics. https://web.archive.org/web/20250911184517/https://www.finddx.org/wp-content/uploads/2022/12/20221208_activity_report_india_2020_FV_EN.pdf ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  21. Sarin, S. (2022, December 8). 2019 Activity Report (p. 25). Foundation for Innovative New Diagnostics. https://web.archive.org/web/20250911194948/https://www.finddx.org/wp-content/uploads/2022/12/20221208_activity_report_india_2019_FV_EN.pdf ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  22. Kessel, M., & Rodriguez, B. (2024, January 10). Activity Report 2022 (p. 24). Foundation for Innovative New Diagnostics. https://web.archive.org/web/20250911183659/https://www.finddx.org/wp-content/uploads/2025/06/20240110_activity_report_2022_FV_EN.pdf ↩︎ ↩︎

  23. Kessel, M., & Boehme, C. (2022, December 8). Annual Report 2019 (p. 24). Foundation for Innovative New Diagnostics. https://web.archive.org/web/20250908042732/https://www.finddx.org/wp-content/uploads/2022/12/20221208_activity_report_2019_FV_EN.pdf ↩︎

  24. Boehme, C., & Kessel, M. (2014, April 2). Annual Report 2013 (p. 50). Foundation for Innovative New Diagnostics. https://web.archive.org/web/20250625053836/https://www.finddx.org/wp-content/uploads/2022/12/20221208_activity_report_2013_FV_EN.pdf ↩︎ ↩︎

  25. Annual Report 2008 (p. 34). (2009, August 10). Foundation for Innovative New Diagnostics. https://web.archive.org/web/20240630203423/https://www.finddx.org/wp-content/uploads/2022/12/20221208_activity_report_2008_FV_EN.pdf ↩︎ ↩︎

  26. Kessel, M., & Boehme, C. (2022a, December 8). Annual Report 2016 (p. 37). Foundation for Innovative New Diagnostics. https://web.archive.org/web/20240630022101/https://www.finddx.org/wp-content/uploads/2022/12/20221208_activity_report_2016_FV_EN.pdf ↩︎ ↩︎

  27. FIND Annual report 2021. Canva; Foundation for Innovative New Diagnostics. Retrieved September 11, 2025, from https://web.archive.org/web/20250911184252/https://annual-report-21.my.canva.site/#page-6 ↩︎

  28. Boehme, C., & Kessel, M. (2022, December 8). Annual Report 2017 (p. 25). Foundation for Innovative New Diagnostics. https://web.archive.org/web/20250907073031/https://www.finddx.org/wp-content/uploads/2022/12/20221208_activity_report_2017_FV_EN.pdf ↩︎

  29. Boehme, C., & Kessel, M. (2015, April 14). Annual Report 2014 (p. 14). Foundation for Innovative New Diagnostics. https://web.archive.org/web/20240630040805/https://www.finddx.org/wp-content/uploads/2022/12/20221208_activity_report_2014_FV_EN.pdf ↩︎

  30. Access to COVID-19 tools funding commitment tracker. (2022, April 1). World Health Organization. https://web.archive.org/web/20220407020319/https://www.who.int/publications/m/item/access-to-covid-19-tools-tracker ↩︎

  31. Corporations, Foundations & Organizations - FY2019. CDC Foundation. Retrieved July 31, 2022, from https://web.archive.org/web/20220731125224/https://www.cdcfoundation.org/FY2019/organizations ↩︎

  32. Annual Report July 2013 - June 2014 (p. 37). Infectious Diseases Institute. Retrieved July 6, 2017, from https://web.archive.org/web/20170706022039/https://idi-makerere.com/index.php?option=com_docman&task=doc_download&gid=88&Itemid=565 ↩︎

  33. Voluntary contributions by fund and by contributor, 2021 (p. 7). (2022). World Health Organization. https://web.archive.org/web/20220516042059/https://apps.who.int/gb/ebwha/pdf_files/WHA75/A75_INF5-en.pdf ↩︎

Profiles
About the author
Liam Sturgess

Liam Sturgess

Liam Sturgess is a Canadian writer, researcher and investigative reporter focused on issues of human rights and civil liberties, with a particular interest in the COVID-19 pandemic. He is the founder of White Rose Intelligence.

Read next

United States Department of Homeland Security

United States Department of Health and Human Services

The Giving Pledge

Forum of Young Global Leaders

Fast Grants

Knowledge is Freedom

Research and intelligence in defense of liberty

White Rose Intelligence

Great! You’ve successfully signed up.

Welcome back! You've successfully signed in.

You've successfully subscribed to White Rose Intelligence.

Your link has expired.

Success! Check your email for magic link to sign-in.

Success! Your billing info has been updated.

Your billing was not updated.